Schrodinger (SDGR) VP details stock, RSU and option holdings

Rhea-AI Filing Summary

Schrodinger, Inc. filed a Form 3 showing VP, Corporate Controller Therese Marie Abrams’ existing equity holdings. She directly holds 19,461 shares of common stock, which include 15,195 unvested restricted stock units that are scheduled to vest in tranches between 2027 and 2030, subject to continued service.

She also holds several stock option awards to buy common stock at exercise prices ranging from $4.34 to $102.48, with expiration dates from 2029 through 2036. Some of these options are fully vested, while others vest over time according to the schedules described.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Abrams Therese Marie

(Last) (First) (Middle)

C/O SCHRODINGER, INC

1540 BROADWAY, 24TH FLOOR

(Street)

NEW YORK NEW YORK 10036

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/08/2026

3. Issuer Name and Ticker or Trading Symbol
Schrodinger, Inc. [ SDGR ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Corporate Controller

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	19,461(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	(2)	01/30/2029	Common Stock	3,067	$4.34	D
Stock Option (right to buy)	(3)	02/04/2030	Common Stock	6,688	$17	D
Stock Option (right to buy)	(4)	02/27/2031	Common Stock	6,200	$102.48	D
Stock Option (right to buy)	(5)	02/09/2032	Common Stock	15,000	$27.76	D
Stock Option (right to buy)	(6)	02/09/2033	Common Stock	5,000	$23.29	D
Stock Option (right to buy)	(7)	03/04/2034	Common Stock	3,398	$25.24	D
Stock Option (right to buy)	(8)	03/03/2035	Common Stock	5,526	$21.24	D
Stock Option (right to buy)	(9)	03/02/2036	Common Stock	5,980	$12.15	D

Explanation of Responses:

1. Includes 15,195 unvested restricted stock units ("RSUs"), comprised of 850 unvested RSUs that will vest on February 9, 2027, (ii) 2,549 unvested RSUs that will vest in equal installments on each of March 5, 2027 and 2028, (iii) 4,836 unvested RSUs that will vest in equal installments on each of March 4, 2027, 2028 and 2029 and (iv) 6,960 unvested RSUs that will vest in equal installments on each of March 9, 2027, 2028, 2029 and 2030, in each case, subject to the Reporting Person's continued service with the company. Each RSU represents a contingent right to receive one share of common stock of the Issuer.

2. The option was granted on January 30, 2019 and is fully vested.

3. The option was granted on February 5, 2020 and is fully vested.

4. The option was granted on February 27, 2021 and is fully vested.

5. The option was granted on February 9, 2022 and is fully vested.

6. The option was granted on February 9, 2023. The shares underlying the option vested with respect to 25% of the shares on February 9, 2024 and the remainder are scheduled to vest in equal monthly installments through February 9, 2027.

7. The option was granted on March 4, 2024. The shares underlying the option vested with respect to 25% of the shares on March 4, 2025 and the remainder are scheduled to vest in equal monthly installments through March 4, 2028.

8. The option was granted on March 3, 2025. The shares underlying the option vested with respect to 25% of the shares on March 3, 2026 and the remainder are scheduled to vest in equal monthly installments through March 3, 2029.

9. The option was granted on March 2, 2026. The shares underlying the option are scheduled to vest with respect to 25% of the shares on March 2, 2027 and the remainder are scheduled to vest in equal monthly installments through March 2, 2030.

Remarks:

1. This Form 3 is being filed late due to an administrative delay in obtaining the reporting person's EDGAR codes. This late filing is not due to any error of the reporting person. 2. Exhibit 24.1 Power of Attorney

	/s/ Donald Shum, as attorney-in-fact for Therese Abrams	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Therese Marie Abrams’ Form 3 for Schrodinger (SDGR) disclose?

The Form 3 discloses Therese Marie Abrams’ existing equity position in Schrodinger, Inc., including common stock, unvested restricted stock units, and multiple stock option grants with specified exercise prices, vesting schedules, and expiration dates spanning from 2029 through 2036.

How many Schrodinger (SDGR) common shares does Therese Abrams report on Form 3?

She reports direct ownership of 19,461 shares of Schrodinger common stock. This figure includes 15,195 unvested restricted stock units that convert into shares as they vest under multi‑year schedules, assuming she continues her service with the company through each vesting date.

What restricted stock units (RSUs) are included in Therese Abrams’ Schrodinger (SDGR) holdings?

Her holdings include 15,195 unvested RSUs that vest in multiple installments between 2027 and 2030. Each RSU represents a contingent right to receive one Schrodinger common share, subject to her continued service with the company through the applicable vesting dates.

What stock options does Therese Abrams hold in Schrodinger (SDGR) according to the Form 3?

She holds several stock option awards to buy Schrodinger common stock at exercise prices ranging from $4.34 to $102.48. These options have expiration dates between 2029 and 2036, with some fully vested and others vesting monthly over future years.

Does Therese Abrams’ Schrodinger (SDGR) Form 3 show any recent insider buying or selling?

The Form 3 functions as an initial ownership report and shows her existing holdings rather than new transactions. The data provided describe current common stock, RSUs, and option positions, without indicating recent open‑market purchases, sales, or option exercises.